Sutent Side Effects Linked to Stevens-Johnson Syndrome (SJS)

Canadian health officials warn that the cancer drug Sutent, which is also sold in the U.S., may cause serious and potentially fatal skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).  

On September 6, Health Canada issued a warning about the side effects of Sutent, indicating that the medication may have caused patient deaths due to SJS and TEN.

Canadian health officials are requiring new information on the warning label for Sutent, but no similar requirement or announcement has been issued in the United States by the FDA.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Stevens-Johnson Syndrome (SJS) is a serious reaction that is known to be caused by several different medications It involves burns to the skin that develop from the inside out, producing blisters, severe rashes, and potentially causing the skin to separate from the body. When the skin lesions affect more than 30% of the body, the condition is typically referred to as Toxic Epidermal Necrolysis (TEN).

Treatment for SJS and TEN usually require inpatient care at a hospital Burn Unit, and it can result in permanent blindness, organ failure and other serious problems.

According to the Canadian warning, out of nearly 215,000 patients who took Sutent between January 26, 2006, and April 30, 2013, there were at least five cases of SJS and four cases of TENS, two of which resulted in the deaths of the patients. None of those cases occurred in Canada and it is unclear whether any occurred in the U.S. from the data Health Canada released.

Sutent (sunitinib malate) is a Pfizer drug approved in the U.S. by the FDA in 2006 for the treatment of cancer of the stomach, kidney, and pancreas. It has a black box warning in the U.S. for liver toxicity, which came after the FDA warned of potential Sutent liver failures in 2009.

Side effects of Sutent can also include cardiac toxicity, heart rhythm problems and bleeding problems. The U.S. warning label indicates that rashes and skin discoloration are among the most common adverse reactions, but mentions nothing indicating the severity of SJS or TENS.

Health Canada is warning health care professionals and patients that Sutent treatment should be discontinued if signs or symptoms of SJS or TENS are present. If the diagnosis of the skin reactions is confirmed, treatment must not be restarted.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.